Dy, G. K., Hillman, S. L., Rowland, K. M., Molina, J. R., Steen, P. D., Wender, D. B., . . . Adjei, A. A. (2010). A Front-Line “Window of Opportunity” Phase II Study of Sorafenib in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)– A North Central Cancer Treatment Group Study N0326(). Cancer.
Stile di citazione ChicagoDy, Grace K., et al. "A Front-Line “Window of Opportunity” Phase II Study of Sorafenib in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)– A North Central Cancer Treatment Group Study N0326()." Cancer 2010.
Citazione MLADy, Grace K., et al. "A Front-Line “Window of Opportunity” Phase II Study of Sorafenib in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)– A North Central Cancer Treatment Group Study N0326()." Cancer 2010.